Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine

Toxicology

Volumn 186, Issue 1-2, 2003, Pages 67-77

  Szaefer, Hanna ^a   Jodynis Liebert, Jadwiga ^a   Cichocki, Michał ^a   Matuszewska, Arleta ^a   Baer Dubowska, Wanda ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Caffeine metabolism; Cytochrome P450; Ellagic acid; o Toluidine; Protocatechuic acid; Tannic acid

Indexed keywords

2 METHYLANILINE; CAFFEINE; CYTOCHROME P450 1A; DRUG METABOLIZING ENZYME; ELLAGIC ACID; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; METHOXYRESORUFIN DEETHYLASE; PENTHOXYRESORUFIN DEETHYLASE; PHENOL DERIVATIVE; PLANT EXTRACT; PROTOCATECHUIC ACID; TANNIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOTRANSFORMATION; CAFFEINE; CARCINOGENS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; ELLAGIC ACID; ENZYME INDUCTION; GLUTATHIONE TRANSFERASE; HYDROLYZABLE TANNINS; HYDROXYBENZOIC ACIDS; KIDNEY; LIVER; MALE; OXIDOREDUCTASES; RATS; RATS, WISTAR; THEOBROMINE; THEOPHYLLINE; TOLUIDINES;

EID: 0037447620     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00615-7     Document Type: Article

References (52)

1. Ahn D., Putt D., Kresty L., Stoner G.D., Fromm D., Hollenberg P.F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis. 17:1996;821-828.
2. Aryton A.D., Lewis D.F.V., Walker R., Ionnides C. Antimutagenicity of ellagic acid towards the food mutagen IQ: investigation into possible mechanisms of action. Food Chem. Toxicol. 30:1992;289-295.
3. Athar M., Khan W.A., Mukhtar H. Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res. 49:1989;5784-5788.
4. Baer-Dubowska W., Gnojkowski J., Fenrych W. Effect of tannic acid on benzo[a]pyrene-DNA adduct formation in mouse epidermis: comparison with synthetic gallic acid esters. Nutr. Cancer. 29:1997;42-47.
5. Baer-Dubowska W., Szaefer H., Krajka-Kuźniak V. Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds. Xenobiotica. 28:1998;735-743.
6. Barch D.H., Fox C.C. Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine. Cancer Lett. 44:1989;39-44.
7. Barch D.H., Rundhaugen L.M., Thomas P.E., Kardos P. Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA. Biochem. Biophys. Res. Commun. 201:1994;1477-1482.
8. Barch D.H., Rundhaugen L.M., Pillay N.S. Ellagic acid induces transcription of the rat glutathione S-transferase-Ya gene. Carcinogenesis. 16:1995;665-668.
9. Berthou F., Flinois J.-P., Ratanasavanh D., Beaune P., Riche C., Guillouzo A. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metab. Dispos. 19:1991;561-567.
10. Berthou F., Guillois B., Riche C., Dreano Y., Jacqz-Aigrain E., Beaune P.H. Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica. 22:1992;671-680.
11. Berthou F., Goasduff T., Dréano Y., Ménez J.-F. Caffeine increases its own metabolism through cytochrome P4501A induction in rats. Life Sci. 6:1995;541-549.
12. Berthou F., Goasduff T., Lucas D., Dreano Y., Le-Bot M.-H., Menez J.-F. Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans. Pharmacogenetics. 5:1995;72-79.
13. Bryant M.S., Vineis P., Skipper P.L., Tannenbaum S.R. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke. IARC Sci. Publ. 89:1998;133-136.
14. Burke M.D., Thompson S., Weaver R.J., Wolf C., Mayers R.T. Cytochrome P450 specificities of alkoxyresorufin-O-dealkylation in human and rat liver. Biochem. Pharmacol. 48:1994;923-936.
15. Danford N. The genetic toxicology of ortho-toluidine. Mutat. Res. 258:1991;207-236.
16. Das M., Bickers D.R., Mukhtar H. Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action. Carcinogenesis. 6:1985;1409-1413.
17. Das M., Mukhtar H., Bik D.P., Bickers D.R. Inhibition of epidermal xenobiotic metabolism in SENCAR mice by naturally occurring plant phenols. Cancer Res. 47:1987;760-766.
18. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402:1998;151-158.
19. Gnojkowski J., Baer-Dubowska W., Klimek D., Chmiel J. Effect of toluidines on drug metabolizing enzymes in rat liver, kidney and lung. Toxicology. 32:1984;335-342.
20. Guengerich F.P. Characterization of roles of human cytochrome P450 enzymes in carcinogen metabolism. Asia Pac. J. Pharmacol. 5:1990;327-345.
21. Gupta R.L., Gupta A.K., Pathak D.P., Juneja T.R. Mutagenic studies of ortho-toluidine and its potential metabolites. Ind. J. Exp. Biol. 25:1987;618-622.
22. Habig W.H., Pabs M.J., Jakoby W.B. Glutathione S-transferase: the first enzymatic steps in mercapturic acid formation. J. Biol. Chem. 249:1974;7130-7139.
23. Hietanen E., Ahotupa M., Bereziat J.C., Park S.S., Gelboin H.V., Bartsh H. Monoclonal antibody characterization of hepatic and extrahepatic cytochrome P450 activities in rats treated with phenobarbital or methylcholanthrene and fed various cholesterol diets. Biochem. Pharmacol. 36:1987;3973-3990.
24. Hirose Y., Tanaka T., Kawamori T., Ohnishi M., Makita H., Mori H., Satoh K., Hara A. Chemoprevention of urinary bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats. Carcinogenesis. 16:1995;2337-2342.
25. IARC, 2000. Some Industrial Chemicals. IARC Monograph on the Evaluation of Carcinogenic Risk Humans. Int. Agency Res. Cancer, Lyon, France. IARC Monogr. 77, 267-268.
26. Jodynis-Liebert J., Matuszewska A. Effect of toluidines and dinitrotoluenes on caffeine metabolic ratio in rat. Toxicol. Lett. 104:1999;159-165.
27. Khan W.A., Wang Z.Y., Athar M., Bickers D.R., Mukhtar H. Inhibition of the skin tumorigenicity of (+/-)-7-beta,8-alpha-dihydroksy-3-alpha,10-alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Lett. 42:1988;7-15.
28. Krajka-Kuźniak, V., Gnojkowski, J., Szaefer, H., Baer-Dubowska, W., 1998. Differential inhibition and induction of cytochrome P450 and II phase enzymes in mouse liver and kidney by plant phenolics - tannic acid and protocatechuic acid. Proceedings of the 15th Meeting, EACR, p. 115.
29. Krajka-Kuźniak V., Gnojkowski J., Baer-Dubowska W. Modulation of hepatic and renal glutathione S-transferase by naturally occurring plant phenolics in rat and mouse. Johnson I.T., Fenwick G.R. Dietary Anticarcinogens and Antimutagens: Chemical and Biological Aspects. 2000;181-183 Royal Society of Chemistry, Cambridge.
30. Kuhnau J. The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet. 24:1976;117-191.
31. Lesca P. Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogenesis. 4:1983;1651-1653.
32. Leslie C., Reidy G.F., Murray M., Stacey N.H. Induction of xenobiotic biotransformation by the insecticide chlordimeform, a metabolite 4-chloro-o-toluidine and a structurally related chemical o-toluidine. Biochem. Pharmacol. 37:1988;2529-2535.
33. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
34. Mori H., Matsunaga K., Tanakamaru Y., Kawabata K., Yamada Y., Sugie S., Nishikawa A. Effects of protocatechuic acid, S-methylmethanethiosulfonate or 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone (KYN-54) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in mice. Cancer Lett. 135:1999;123-127.
35. Mukhtar H., Das M., Bickers D.R. Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/C mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Res. 46:1986;2262-2265.
36. Mukhtar H., Das M., Khan W.A., Wang Z.Y., Bik D.P., Bickers D.R. Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz[a]anthracene-, benzo[a]pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res. 48:1988;2361-2365.
37. Nakamura H., Nishikawa A., Furukawa F., Kasahara K., Miyauchi M., Son H.-Y., Hirose M. Inhibitory effects of protocatechuic acid on the post-initiation phase of hamster pancreatic carcinogenesis induced by N-nitrosobis(2-oxopropyl)amine. Anticancer Res. 20:2000;3423-3427.
38. Newmark H. Plant phenolics as inhibitors of mutational and precarcinogenic events. Can. J. Physiol. Pharmacol. 65:1987;461-466.
39. Ohnishi M., Yoshimi N., Kawamori T., Ino N., Hirose Y., Tanaka T., Yamahara J., Miyata H., Mori H. Inhibitory effects of dietary protocatechuic acid and costunolide on 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Jpn. J. Cancer Res. 88:1997;111-119.
40. Sellers C., Markowitz S. Reevaluating the carcinogenicity of ortho-toluidine: a new conclusion and its implications. Regul. Toxicol. Pharmacol. 16:1992;301-317.
41. Smart R.C., Huang M.T., Chang R.L., Sayer J.M., Jerina D.M., Conney A.H. Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3-di-O-methylellagic acid in mice. Carcinogenesis. 7:1986;1663-1667.
42. Soon Son O.C.K., Everett D.W., Fiala E.S. Metabolism of o-[methyl-14C] toluidine in the F344 rat. Xenobiotica. 10:1980;457-468.
43. Spanos G.A., Wrolstad R.E. Phenolics of apple, pear and white grape juices and their changes with processing and storage: a review. J. Agric. Food Chem. 40:1992;1478-1487.
44. Stoner G.D., Mukhtar H. Polyphenols as cancer chemopreventive agents. J. Cell. Biochem. Suppl. 22:1995;169-180.
45. Tanaka T., Kojima T., Kawamori T., Yoshimi N., Mori H. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Lett. 53:1993;2775-2779.
46. Tanaka T., Kawamori T., Ohnishi M., Okamoto K., Mori H., Hara A. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and post-initiation phases. Cancer Res. 54:1994;2359-2365.
47. Tanaka T., Ohnishi M., Kojima T., Mori H., Satoh K., Hara A. Chemoprevention of N-methyl-N-nitrosourea-induced rat glandular stomach carcinogenesis by a natural product - protocatechuic acid. Cancer J. 8:1995;150-156.
48. Tanaka T., Kojima T., Kawamori T., Mori H. Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer. 75:1995;1433-1439.
49. Tassaneeyakul W., Birkett D.J., McManus M.E., Tassaneeyakul W., Veronese M.E., Andersson T., Tukey R.H., Miners J.O. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A1, 2E1 and 3A isoforms. Biochem. Pharmacol. 47:1994;1767-1776.
50. Vance R.E., Teel R.W. Effect of tannic acid on rat liver S9 mediated mutagenesis, metabolism and DNA binding of benzo[a]pyrene. Cancer Lett. 47:1989;37-44.
51. Wilson T., Lewis M.J., Cha K.L., Gold B. The effect of ellagic acid on xenobiotic metabolism by cytochrome P450 2E1 and nitrosodimethylamine mutagenicity. Cancer Lett. 61:1992;129-134.
52. Yang C.S., Lee M.J., Chen L., Yang G. Polyphenols as inhibitors of carcinogenesis. Environ. Health Perspect. 105:1997;971-976.